Mesenchymal Stem Cell-based Cancer Gene Therapy: Application and Unresolved Problems

References (82)

1. 1 HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses [DOI]
2. 2 Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals [DOI]
3. 3 Angiogenesis Gene Therapy [DOI]
4. 4 Progress and prospects: immune responses to viral vectors [DOI]
5. 5 Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve Injury [DOI]
6. 6 Mesenchymal stem cell inhibition of T‐helper 17 cell‐ differentiation is triggered by cell–cell contact and mediated by prostaglandin E2 via the EP4 receptor [DOI]
7. 7 Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals [DOI]
8. 8 Stem cell homing in musculoskeletal injury [DOI]
9. 9 The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disorders [DOI]
10. 10 IL1β Induces Mesenchymal Stem Cells Migration and Leucocyte Chemotaxis Through NF-κB [DOI]
11. 11 Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway [DOI]
12. 12 Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion [DOI]
13. 13 Repair of Critical-Sized Rat Calvarial Defects Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells Overexpressing Hypoxia-Inducible Factor-1α [DOI]
14. 14 Human Mesenchymal Stem Cells Constitutively Express Chemokines and Chemokine Receptors That Can Be Upregulated by Cytokines, IFN-β, and Copaxone [DOI]
15. 15 Genetically modified adipose tissue−derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice [DOI]
16. 16 Human adipose tissue‐derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma [DOI]
17. 17 Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice [DOI]
18. 18 Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model [DOI]
19. 19 Therapeutic Applications of Mesenchymal Stem Cells to Repair Kidney Injury [DOI]
20. 20 Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma [DOI]
21. 21 Mesenchymal Stem Cells Display Tumor-Specific Tropism in an RCAS/Ntv-a Glioma Model [DOI]
22. 22 Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model [DOI]
23. 23 Cellular immune response to cryptic epitopes during therapeutic gene transfer [DOI]
24. 24 The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase [DOI]
25. 25 Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling [DOI]
26. 26 Modulated expression of adhesion molecules and galectin-1: Role during mesenchymal stromal cell immunoregulatory functions [DOI]
27. 27 Combination Treatment of Human Umbilical Cord Matrix Stem Cell-Based Interferon-Beta Gene Therapy and 5-Fluorouracil Significantly Reduces Growth of Metastatic Human Breast Cancer in SCID Mouse Lungs [DOI]
28. 28 Enhancement of MSC adhesion and therapeutic efficiency in ischemic heart using lentivirus delivery with periostin [DOI]
29. 29 Cytosine deaminase‐producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model [DOI]
30. 30 Reversal of neuropathic pain by HSV-1-mediated decrease of noradrenaline in a pain facilitatory area of the brain [DOI]
31. 31 The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model [DOI]
32. 32 IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand [DOI]
33. 33 A Clinical Trial of Gene Therapy for Chronic Pain [DOI]
34. 34 Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models [DOI]
35. 35 Involvement of the transcription factor twist in phenotype alteration through epithelial–mesenchymal transition in lung cancer cells [DOI]
36. 36 Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma [DOI]
37. 37 Intratumoral Adenovirus-Mediated Suicide Gene Transfer for Hepatic Metastases from Colorectal Adenocarcinoma: Results of a Phase I Clinical Trial [DOI]
38. 38 A human trial of HSV-mediated gene transfer for the treatment of chronic pain [DOI]
39. 39 Migration and fate of therapeutic stem cells in different brain disease models [DOI]
40. 40 Identification of Galectin-1 as a Critical Factor in Function of Mouse Mesenchymal Stromal Cell-Mediated Tumor Promotion [DOI]
41. 41 Treatment of experimental autoimmune encephalomyelitis in SJL/J mice with a replicative HSV-1 vector expressing interleukin-5 [DOI]
42. 42 Effects of heme oxygenase-1 gene modulated mesenchymal stem cells on vasculogenesis in ischemic swine hearts.
43. 43 Restoration of muscle fibers and satellite cells after isogenic MSC transplantation with microdystrophin gene delivery [DOI]
44. 44 HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy [DOI]
45. 45 Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect [DOI]
46. 46 Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin45-132 inhibit the growth of prostate cancer [DOI]
47. 47 Immunosuppression et cellules souches mésenchymateuses [DOI]
48. 48 Engineering Human Mesenchymal Stem Cells to Release Adenosine Using miRNA Technology [DOI]
49. 49 Chronic Active Herpes Simplex Type 2 Encephalitis in an Asymptomatic Immunocompetent Child [DOI]
50. 50 Synthetic radiation-inducible promoters mediated HSV-TK/GCV gene therapy in the treatment of oral squamous cell carcinoma [DOI]
51. 51 Immunosuppressive Properties of Mesenchymal Stem Cells: Advances and Applications [DOI]
52. 52 Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression [DOI]
53. 53 The Coxsackievirus-Adenovirus Receptor Protein Can Function as a Cellular Attachment Protein for Adenovirus Serotypes from Subgroups A, C, D, E, and F [DOI]
54. 54 Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E2 Signaling [DOI]
55. 55 Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor Growth [DOI]
56. 56 HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells [DOI]
57. 57 The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis [DOI]
58. 58 Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma [DOI]
59. 59 Mesenchymal stem cells enhance lung cancer initiation through activation of IL-6/JAK2/STAT3 pathway [DOI]
60. 60 Thymidine Kinase Gene Modified Bone Marrow Mesenchymal Stem Cells as Vehicles for Antitumor Therapy [DOI]
61. 61 The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity [DOI]
62. 62 Interleukin-10 Delivery via Mesenchymal Stem Cells: A Novel Gene Therapy Approach to Prevent Lung Ischemia–Reperfusion Injury [DOI]
63. 63 Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue [DOI]
64. 64 Targeted Intra-arterial Transplantation of Stem Cells to the Injured CNS is more Effective than Intravenous Administration: Engraftment is Dependent on Cell Type and Adhesion Molecule Expression [DOI]
65. 65 A Phase I Clinical Trial of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Patients with Recurrent Gynecologic Cancer [DOI]
66. 66 Immune barriers to successful gene therapy [DOI]
67. 67 LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response [DOI]
68. 68 RETRACTED: Ischemia postconditioning and mesenchymal stem cells engraftment synergistically attenuate ischemia reperfusion-induced lung injury in rats [DOI]
69. 69 Adenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses [DOI]
70. 70 Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease [DOI]
71. 71 Mesenchymal stem cells as vehicles for targeted delivery of anti‐angiogenic protein to solid tumors [DOI]
72. 72 The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system [DOI]
73. 73 Synergy of a Herpes Oncolytic Virus and Paclitaxel for Anaplastic Thyroid Cancer [DOI]
74. 74 Human umbilical blood mononuclear cell–derived mesenchymal stem cells serve as interleukin‐21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice [DOI]
75. 75 Paracrine Signaling between Carcinoma Cells and Mesenchymal Stem Cells Generates Cancer Stem Cell Niche via Epithelial–Mesenchymal Transition [DOI]
76. 76 Lentiviral Vector Transduction of Fetal Mesenchymal Stem Cells [DOI]
77. 77 Therapeutic potential of bone marrow-derived mesenchymal stem cells producing pigment epithelium-derived factor in lung carcinoma [DOI]
78. 78 [Human umbilical cord mesenchymal stem cells with adenovirus-mediated interleukin 12 gene transduction inhibits the growth of ovarian carcinoma cells both in vitro and in vivo].
79. 79 Development of a Regulatable Oncolytic Herpes Simplex Virus Type 1 Recombinant Virus for Tumor Therapy [DOI]
80. 80 Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma [DOI]
81. 81 [Hepatocyte growth factor combined with autologous bone marrow mesenchymal stem cell transplantation for treatment of silicosis].
82. 82 [Research progress of bone marrow mesenchymal stem cells in acute lung injury].

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

• Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
• Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
• Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
• Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
• Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage